Skip to Content

Fluxid FDA Approval History

FDA Approved: Yes (Discontinued) (First approved September 24, 2004)
Brand name: Fluxid
Generic name: famotidine
Dosage form: Orally Disintegrating Tablets
Company: Schwarz Pharma, Inc.
Treatment for: Duodenal Ulcer, Stomach Ulcer, GERD, Zollinger-Ellison Syndrome

Marketing Status: Discontinued

Fluxid (famotidine orally disintegrating tablets) is a histamine H2-receptor antagonist indicated for the treatment of ulcers, gastroesophageal reflux disease and pathological hypersecretory conditions.

Development Timeline for Fluxid

DateArticle
Sep 24, 2004Approval Fluxid Schwarz Pharma, Inc. - Treatment for Ulcers and other Gastrointestinal Conditions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.